Psychological distress among Italians during the 2019 coronavirus disease (COVID-19) quarantine.


Journal

BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559

Informations de publication

Date de publication:
08 01 2021
Historique:
received: 31 07 2020
accepted: 22 12 2020
entrez: 9 1 2021
pubmed: 10 1 2021
medline: 14 1 2021
Statut: epublish

Résumé

Quarantine as a preventive action to reduce people's exposure to a contagious disease has substantial psychological impact. We aimed to collect information on psychologically distressing experiences of Italians living in quarantine during the COVID-19 pandemic. From 6 to 20 April 2020 participants filled out an online questionnaire. Demographic and physical symptoms data from the prior 14 days of quarantine were collected. Psychological impact of quarantine was assessed by the COVID-19 Peritraumatic Distress Index (CPDI). In all, 20,158 participants completed the online survey. Of these, 11,910 (59.1%) were from Lombardy, the region with 37.7% of positive cases identified during the survey period. 30.1% of responders were male. About half (55.9%) of responders were 18-50 years old, 54.3% had a tertiary level of education, 69.5% were workers, 84.1% were living in houses with ≥3 rooms, and 13.7% were living alone. 9.7% had had contact with COVID-19 positive people. Of all responders, 9978 (48.6%) reported a psychological impact, 8897 (43.4%) of whom reported mild or moderate and 1081 (5.2%) severe psychological impact. The multivariate analysis, after adjustments, showed that an increasing CPDI score was associated with gender (female), first-second educational level, being unemployed, living in a ≤2 room house, having had new health problems during the previous 14 days, and not having been out of the house in the previous week. Concerning the type of psychological distress, 2003 responders (9.9%) reported moderate to severe depressive symptoms, 1131 (5.5%) moderate to severe anxiety symptoms, and 802 (3.9%) moderate to severe physical symptoms. A positive correlation was found between responder rate (per 10.000 residents) and positive COVID-19 cases (per 10.000 residents) by region (r Policy makers and mental health professionals should be aware of quarantine's adverse mental health consequences. Factors influencing the success of quarantine and infection control practices for both disease containment and community recovery should be identified and additional support to vulnerable persons at increased risk of adverse psychological and social consequences of quarantine should be guaranteed.

Sections du résumé

BACKGROUND
Quarantine as a preventive action to reduce people's exposure to a contagious disease has substantial psychological impact. We aimed to collect information on psychologically distressing experiences of Italians living in quarantine during the COVID-19 pandemic.
METHODS
From 6 to 20 April 2020 participants filled out an online questionnaire. Demographic and physical symptoms data from the prior 14 days of quarantine were collected. Psychological impact of quarantine was assessed by the COVID-19 Peritraumatic Distress Index (CPDI).
RESULTS
In all, 20,158 participants completed the online survey. Of these, 11,910 (59.1%) were from Lombardy, the region with 37.7% of positive cases identified during the survey period. 30.1% of responders were male. About half (55.9%) of responders were 18-50 years old, 54.3% had a tertiary level of education, 69.5% were workers, 84.1% were living in houses with ≥3 rooms, and 13.7% were living alone. 9.7% had had contact with COVID-19 positive people. Of all responders, 9978 (48.6%) reported a psychological impact, 8897 (43.4%) of whom reported mild or moderate and 1081 (5.2%) severe psychological impact. The multivariate analysis, after adjustments, showed that an increasing CPDI score was associated with gender (female), first-second educational level, being unemployed, living in a ≤2 room house, having had new health problems during the previous 14 days, and not having been out of the house in the previous week. Concerning the type of psychological distress, 2003 responders (9.9%) reported moderate to severe depressive symptoms, 1131 (5.5%) moderate to severe anxiety symptoms, and 802 (3.9%) moderate to severe physical symptoms. A positive correlation was found between responder rate (per 10.000 residents) and positive COVID-19 cases (per 10.000 residents) by region (r
CONCLUSIONS
Policy makers and mental health professionals should be aware of quarantine's adverse mental health consequences. Factors influencing the success of quarantine and infection control practices for both disease containment and community recovery should be identified and additional support to vulnerable persons at increased risk of adverse psychological and social consequences of quarantine should be guaranteed.

Identifiants

pubmed: 33419391
doi: 10.1186/s12888-020-03027-8
pii: 10.1186/s12888-020-03027-8
pmc: PMC7793386
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20

Références

Int J Environ Res Public Health. 2020 May 02;17(9):
pubmed: 32370116
Global Health. 2020 Jul 6;16(1):57
pubmed: 32631403
Riv Psichiatr. 2020 May-Jun;55(3):145-151
pubmed: 32489191
Compr Psychiatry. 2012 Jan;53(1):15-23
pubmed: 21489421
Int J Environ Res Public Health. 2020 May 25;17(10):
pubmed: 32466251
Indian J Psychol Med. 2020 Jul 6;42(4):368-373
pubmed: 33398225
Sleep Med. 2020 Nov;75:12-20
pubmed: 32853913
Soc Psychiatry Psychiatr Epidemiol. 2020 Aug;55(8):965-968
pubmed: 32472197
BMC Psychiatry. 2020 Oct 6;20(1):491
pubmed: 33023563
Child Adolesc Psychiatry Ment Health. 2020 May 12;14:20
pubmed: 32419840
Int J Environ Res Public Health. 2020 Jun 02;17(11):
pubmed: 32498401
J Sleep Res. 2020 Aug;29(4):e13074
pubmed: 32410272
Soc Psychiatry Psychiatr Epidemiol. 2006 Nov;41(11):853-61
pubmed: 16915360
Pharmacopsychiatry. 2020 Sep;53(5):237-238
pubmed: 32583390
Depress Anxiety. 2013 Apr;30(4):321-7
pubmed: 23408506
Gen Hosp Psychiatry. 2009 Jul-Aug;31(4):318-26
pubmed: 19555791
Epidemiol Health. 2016 Nov 5;38:e2016048
pubmed: 28196409
Science. 1987 Apr 17;236(4799):280-5
pubmed: 3563507
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
Soc Sci Med. 2020 Dec;266:113364
pubmed: 32950924
Nutrients. 2020 Jul 19;12(7):
pubmed: 32707724
Psychol Sci. 2006 Apr;17(4):278-82
pubmed: 16623682
BMC Public Health. 2008 Oct 03;8:347
pubmed: 18831770
Int J Environ Res Public Health. 2020 Jul 02;17(13):
pubmed: 32630821
Psychiatr Serv. 2004 Sep;55(9):1055-7
pubmed: 15345768
Psychol Trauma. 2020 May;12(4):331-335
pubmed: 32271070
Risk Manag Healthc Policy. 2020 Jul 07;13:733-742
pubmed: 32753986
Gen Psychiatr. 2020 Mar 6;33(2):e100213
pubmed: 32215365
Asian J Psychiatr. 2020 Jun;51:102127
pubmed: 32344330
Front Psychiatry. 2020 Aug 07;11:790
pubmed: 32848952
Lancet Psychiatry. 2020 Jul;7(7):611-627
pubmed: 32437679
Bull World Health Organ. 2016 Mar 1;94(3):210-4
pubmed: 26966332
PLoS One. 2020 Apr 16;15(4):e0231924
pubmed: 32298385
Asian J Psychiatr. 2020 Aug;52:102066
pubmed: 32302935
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Public Health. 2020 Jun;183:4-5
pubmed: 32388010
Ann Acad Med Singap. 2020 Jan;49(3):155-160
pubmed: 32200399
Lancet. 2020 Mar 28;395(10229):1047-1053
pubmed: 32199075
Emerg Infect Dis. 2004 Jul;10(7):1206-12
pubmed: 15324539
Epidemiol Health. 2020;42:e2020038
pubmed: 32512661
Public Health. 2020 Jun;183:38-39
pubmed: 32417566
Int J Infect Dis. 2020 Feb;91:264-266
pubmed: 31953166
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
JAMA. 2020 Jul 7;324(1):93-94
pubmed: 32492088
Epidemiol Infect. 2020 May 20;148:e96
pubmed: 32430086
N Engl J Med. 2020 Aug 6;383(6):510-512
pubmed: 32283003
Epidemiol Infect. 2008 Jul;136(7):997-1007
pubmed: 17662167
Psychiatry Res. 2020 Jun;288:112998
pubmed: 32325386
Asian J Psychiatr. 2020 Jun;51:102076
pubmed: 32334409
Brain Behav Immun. 2020 Jul;87:124-125
pubmed: 32360603

Auteurs

Maurizio Bonati (M)

Department of Public Health, Laboratory for Mother and Child Health, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy. maurizio.bonati@marionegri.it.

Rita Campi (R)

Department of Public Health, Laboratory for Mother and Child Health, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.

Michele Zanetti (M)

Department of Public Health, Laboratory for Mother and Child Health, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.

Massimo Cartabia (M)

Department of Public Health, Laboratory for Mother and Child Health, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.

Francesca Scarpellini (F)

Department of Public Health, Laboratory for Mother and Child Health, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.

Antonio Clavenna (A)

Department of Public Health, Laboratory for Mother and Child Health, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.

Giulia Segre (G)

Department of Public Health, Laboratory for Mother and Child Health, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH